Question 1

What are the potential side effects of Rocbrutinib and Lacutoclax?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any restrictions on my diet or medications while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies clinical trial (NCT07609862). Contact the study team or your healthcare provider for specific answers.

What this study is about